NCT06786039 Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants
| NCT ID | NCT06786039 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Korea University Anam Hospital |
| Condition | Preterm Infant |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2029-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2025-01-20 with a primary completion date of 2029-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective observational study investigating the impact of NIV-NAVA on short-term clinical outcomes and long-term neurodevelopment in very preterm infants.
Eligibility Criteria
Inclusion Criteria: * Preterm infants born between 27 weeks 0 days to 31 weeks 6 days of gestation * Preterm infants who require respiratory support within the first 48 hours of life Exclusion Criteria: * Preterm infants who die within the first 48 hours of life * Preterm infants who do not require any respiratory support within the first 48 hours of life. * Preterm infants with congenital anomalies affecting the lungs, heart, or other organs that could influence breathing * Infants whose parents do not consent to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06786039 clinical trial?
This trial is open to participants of all sexes, aged 1 Hour or older, up to 48 Hours, studying Preterm Infant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06786039 currently recruiting?
Yes, NCT06786039 is actively recruiting participants. Contact the research team at juyounglee@korea.ac.kr for enrollment information.
Where is the NCT06786039 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea, Seoul, South Korea.
Who is sponsoring the NCT06786039 clinical trial?
NCT06786039 is sponsored by Korea University Anam Hospital. The trial plans to enroll 80 participants.